Jack Christopher O'Brien

Jack O'Brien practices at UT of Texas Southwestern University Hospital - William P. Clements Jr. - HOPD (5939 Harry Hines Blve) in Dallas, Texas.

Jack O'Brien's NPI, 1639600596, was assigned on March 22, 2017. Jack O'Brien graduated from UT Southwestern Medical Center in 2017. Jack O'Brien holds Texas license T1497.

Jack O'Brien's primary practice is UT of Texas Southwestern University Hospital - William P. Clements Jr. - HOPD (5939 Harry Hines Blve), at 5939 Harry Hines Blve, Dallas, TX 75235.

Jack O'Brien's primary practice is UT of Texas Southwestern University Hospital - William P. Clements Jr. - HOPD (5939 Harry Hines Blve) in Dallas, Texas. Jack O'Brien is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Jack O'Brien to 1 more hospital and 1 group practice or clinic, each named with a free account. Jack O'Brien's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Jack O'Brien practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Jack O'Brien's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Jack O'Brien is board certified in dermatology by the American Board of Dermatology. Jack O'Brien is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Jack O'Brien treats.

CMS data shows 3,787 Medicare services from Jack O'Brien across 22 procedure codes in 2024, for 801 Medicare patients. Medicare paid $171,451 for them.

CMS counts 801 Medicare patients who saw Jack O'Brien in 2024. The largest group is 65 to 74, with 362 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jack O'Brien's median patient age at 63, with 52% women.

In 2024, Jack O'Brien wrote 1,872 Medicare Part D claims for 498 patients. 82% of them were for generic drugs. CMS names the drug for 1,628 of them, across 36 drugs with 11 or more claims each, at $2,196,266 in total drug cost. In 2023, CMS named 1,265 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Jack O'Brien for performance year 2024, reported as part of a group. Jack O'Brien accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jack O'Brien as offering telehealth. CMS counts 496 procedures of skin biopsy by Jack O'Brien, more than 95% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Jack O'Brien, published from 2016 to 2021. The most frequent topics are Scleroderma, Localized, Lupus Erythematosus, Cutaneous and Lupus Erythematosus, Discoid. Jack O'Brien has published most often in J Am Acad Dermatol. Jack O'Brien's most frequent co-authors are Benjamin F. Chong, MD, Heidi T. Jacobe, MD and Majid Chalian, MD.

CMS Open Payments shows 41 general payments to Jack O'Brien from 7 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 82% of the total. Incyte Corporation paid the most, $9,443.

Jack O'Brien graduated from UT Southwestern Medical Center in 2017.

Jack O'Brien is in network with 18 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.